Thymosin .alpha.1 promotes tissue repair, angiogenesis and cell migration
Patent Number: 6197751
Date of First Priority Issue: Friday November 7th, 1997
Date Issued: Tuesday March 6th, 2001
Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC)
Inventors: Malinda, Katherine M. (Millersville, MD); Kleinman, Hynda K. (Kensington, MD); Goldstein, Allan L. (Washington, DC)
From Class: Expansion
Comments: No comments
Thymosin is expressed by the thymus and is associated with immune stimulation. In this patent the ability of thymosin to augment regeneration of tissue, as well as stimulate stem cells is patented.
It is interesting that the production of thymosin actually decreases, as well as general thymic function with age. This patent may be a way to induce longevity by administration of thymosin.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.